Number of the records: 1  

Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours

  1. 1.
    0024471 - ÚMG 2006 RIV GR eng J - Journal Article
    Indrová, Marie - Bieblová, Jana - Jandlová, Táňa - Vonka, V. - Pajtasz-Piasecka, E. - Reiniš, Milan
    Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.
    [Chemoterapie, genová terapie IL-12 a kombinovaná adjuvantní terapie MHC I+ a MHC I- nádorů vyvolaných HP 16.]
    International Journal of Oncology. Roč. 28, č. 1 (2006), s. 253-260. ISSN 1019-6439. E-ISSN 1791-2423
    R&D Projects: GA MZd(CZ) NR7807; GA MZd(CZ) NR8004
    Grant - others:Ministry of Scientific Research Information Society Technologies(PL) PBZ-KBN-091/PO5/2003
    Institutional research plan: CEZ:AV0Z50520514
    Keywords : HPV16 * MHC class I-deficient and MHC class I-proficient tumour cells * CMRTD
    Subject RIV: EC - Immunology
    Impact factor: 2.556, year: 2006

    Permanent Link: http://hdl.handle.net/11104/0115008
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.